A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function
Clinical trial NCT05706623 · COMPLETED
Trial details
- NCT number
- NCT05706623
- Sponsor
- VectivBio AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2023-04-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.